Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for RSV Clinical Trials
RSV clinical trials are recruiting across 69 cities. Here are the cities with the most active studies:
RSV Trial Phases
16 research organizations are sponsoring rsv trials.
About RSV
Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms but can be serious in infants, older adults, and immunocompromised individuals. New preventive therapies including monoclonal antibodies and vaccines have recently been approved. Clinical trials continue to investigate improved treatments.
Clinical trials are advancing new treatments for rsv. Currently, 16 studies are recruiting a combined 13,841 participants across the United States. Research is being conducted by 16 organizations including Yale University, Sanofi, CorEvitas and 13 others.
2026 RSV Research Landscape
As of August 2026, the rsv clinical trial landscape includes 16 actively recruiting studies across 69 cities in the United States. These studies are collectively seeking 13,841 participants, with an average enrollment target of 865 per study.
The research spans multiple phases of development: 8 studies are in PHASE2, 5 studies are in PHASE1, 2 studies are in NA, 2 studies are in PHASE3, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some rsv treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 16 different organizations, including Yale University, Sanofi, CorEvitas, GlaxoSmithKline, DiaSorin Molecular LLC, and 11 others. The large number of sponsors reflects significant research interest and investment in rsv treatment advancement.
Geographically, rsv trials are most concentrated in New Haven, Connecticut (2 trials); Long Beach, California (2 trials); San Diego, California (2 trials); Lenexa, Kansas (2 trials); Seattle, Washington (2 trials) and 7 other cities.
Featured RSV Studies
Highlighted recruiting studies for rsv, selected by enrollment size and research scope.
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
The purpose of this study is to continue evaluating how well the RSV vaccines work as they are currently being used in routine clinical practice. Some of the questions that the investigators hope to answer with this study are: 1) What is the overall effectiveness of these vaccines? 2) How long does immunity last? 3) How effective are the vaccines against new strains? 3) Does the vaccine's effectiv...
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
This study is a Phase 1/2, randomized, observer-blind, active and placebo-controlled, multi-center study to be conducted in approximately 2400 adults 60 years of age and older. The aim of the study is to evaluate the immunogenicity and safety of an RSV+HMPV vaccine candidate for the prevention of RSV and HMPV disease among adults 60 years of age and older. While there are 3 FDA approved/licensed R...
RSV Vaccine Pregnancy Registry
The research question is: What is the risk of adverse pregnancy outcomes, including preterm birth, hypertensive disorders, and other maternal and neonatal/infant outcomes, following exposure to RSV vaccine between 32 weeks, 0 days and 36 weeks, 6 days of gestation in the CorEvitas Respiratory Syncytial Virus Vaccine Pregnancy Registry (RSV-PR)? The primary study objective is to estimate the risk o...
Frequently Asked Questions About RSV Clinical Trials
Are there rsv clinical trials near me?
Yes, there are 16 rsv clinical trials currently recruiting across 69+ cities in the United States, including New Haven, Connecticut; Long Beach, California; San Diego, California. Browse the studies above to find one at a location convenient for you.
How do I join a rsv clinical trial?
To join a rsv clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are rsv clinical trials free?
Yes, participation in rsv clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of rsv treatments are being studied?
Current rsv clinical trials are testing a range of approaches across PHASE2 (8 studies), PHASE1 (5 studies), NA (2 studies), PHASE3 (2 studies), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 16 research organizations.
Is it safe to participate in rsv clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated August 30, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated August 30, 2026 · Data from ClinicalTrials.gov